Table II.
Information of cervical cancer patients and healthy controls in Solexa sequencing.
| Variables | Cervical cancer cases, no. (%) (n=90) | Controls, no. (%) (n=64) |
|---|---|---|
| Age, years | ||
| (mean ± SD) | 46.0±9.3 | 46.0±7.1 |
| ≥55 | 24 (26.5) | 13 (20.3) |
| 45–54 | 42 (47.0) | 27 (42.2) |
| <45 | 24 (26.5) | 24 (37.5) |
| Histological differentiation | ||
| Poor | 9 (10.5) | |
| Moderate | 50 (55.3) | |
| High | 31 (34.2) | |
| FIGO stage | ||
| 0 (CIN) | 33 (36.4) | |
| I | 45 (50.0) | |
| II | 11 (12.1) | |
| III | 1 (1.5) |
FIGO, International Federation of Gynecology and Obstetrics; CIN, cervical intraepithelial neoplasia.